This study provides the first evidence that CaMKII activation differentially regulates Cav3.2 T-type calcium channels by potentiating channel opening at negative voltages.
No takes yet. Share an insight, caveat, or question.
Should not yet guide clinical CaMKII or T-type channel targeting; leaves open mechanistic validation in human cardiovascular models.
Wolfe et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: